(a) Specifications.
Diatrizoate meglumine oral solution is a water soluble radiopaque medium containing 66 percent diatrizoate meglumine and 10 percent diatrizoate sodium.
(b) Sponsor.
See No. 053501 in § 510.600(c) of this chapter.
(c) Conditions of use.
(1)
It is indicated for radiography of the gastrointestinal tract in dogs and cats.
(2)
It is administered orally at a dosage level of 0.5 to 1.0 milliliter per pound of body weight by gavage or stomach tube. It is administered rectally at a dosage level of 0.5 to 1.0 milliliter per pound of body weight diluted with 1 part of the drug to 5 parts of water.
(3)
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Code of Federal Regulations
[44 FR 12993, Mar. 9, 1979, as amended at 50 FR 41489, Oct. 11, 1985]